HA-1 Activators
HA-1 Activators refers to a specific class of chemical compounds that interact with the human antigen 1 (HA-1) protein, playing a crucial role in cellular processes and immune responses. HA-1, also known as minor histocompatibility antigen 1, is a protein that is expressed on the surface of cells and plays a key role in immune recognition. The HA-1 Activators are characterized by their ability to modulate the function or expression of the HA-1 protein, thereby influencing cellular interactions and immune responses within the human body.
Structurally, HA-1 Activators possess distinctive molecular features that enable them to bind selectively to HA-1, triggering a cascade of intracellular events. These compounds may act as agonists, stimulating specific cellular pathways associated with HA-1, or as modulators, regulating the expression levels of HA-1 on cell surfaces. The interaction between HA-1 Activators and the HA-1 protein is highly specific, highlighting the precision of these compounds in targeting key elements of the immune system. Researchers and scientists are actively exploring the pharmacological implications and potential applications of HA-1 Activators in various biological contexts, seeking to deepen our understanding of the intricate interplay between these compounds and the immune system. The intricate details of the molecular mechanisms underlying HA-1 activation are subjects of ongoing research, and the exploration of this chemical class opens new avenues for unraveling the complexities of immune regulation and cellular responses in health and disease.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, which increases intracellular cAMP levels. Elevated cAMP can enhance HA-1 activity by phosphorylation through PKA-dependent mechanisms. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 engages EP2 and EP4 receptors, leading to increased cAMP production. This rise in cAMP can subsequently augment HA-1 activity through PKA signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, preventing the breakdown of cAMP. Elevated cAMP levels can enhance HA-1 function through PKA-mediated pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to beta-adrenergic receptors, activating Gs proteins and subsequently adenylate cyclase, increasing cAMP levels, which may enhance HA-1 activity via PKA. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can indirectly enhance HA-1 activity by modulating the JNK pathway, which may affect transcription factors that regulate HA-1 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable analog of cAMP that directly elevates intracellular cAMP levels, enhancing HA-1 activity through PKA-dependent phosphorylation. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, leading to increased cAMP and cGMP levels, which could enhance HA-1 activity via PKA or PKG pathways. | ||||||
Sp-cAMPS | 93602-66-5 | sc-201571 | 1 mg | $97.00 | 3 | |
Sp-cAMPS is a PKA activator due to its resistance to degradation by phosphodiesterases, thereby maintaining elevated cAMP levels and enhancing HA-1 activity. | ||||||